Icon

CATAPRES-TTS-3 (nda018891)- (0.3MG/24HR)

CLONIDINE LAVIPHARM
0.3MG/24HR
Yes No
2003-May-04 Expired
None None
None No
Catapres-TTS transdermal therapeutic system is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
4 0 3
Total Other Developers 1
Drugs with Suitability No
0.3MG/24HR ** ** - 3 -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** ****** ***********, ***. *********** **** **** ****** **, ***** ******, ******** (**) *****, ****** ****** (***) ***
****** ******* **** ** *** ******* ************ **, ***. *********** *** ******* ***, **** **** ****, **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.